This topic contains a solution. Click here to go to the answer

Author Question: Consider the following data: the height in centimeters of children in a third-grade class. Which of ... (Read 134 times)

rayancarla1

  • Hero Member
  • *****
  • Posts: 571
Consider the following data: the height in centimeters of children in a third-grade class. Which of the following best describes these data?
 a. Attribute data
  b. Qualitative data
  c. Quantitative data
  d. Sample data

Question 2

Which of the following best describes the data: classifications of unlikely, likely, or very likely to describe possible buying of a product?
 a. Attribute data
  b. Numerical data
  c. Quantitative data
  d. Sample data



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mochi09

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

C

Answer to Question 2

A




rayancarla1

  • Member
  • Posts: 571
Reply 2 on: Jul 24, 2018
Excellent


Kedrick2014

  • Member
  • Posts: 359
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library